MYC and esophageal squamous cell carcinoma: In consistency with PI3Kα-independent activation of mTORC1, MAPK, and c-Myc signaling in CYH33-resistant ESCC cells, simultaneous inhibition of PI3Kα and mTORC1, MEK, or BET displayed synergistic activity against the proliferation of the resistant cells.